Presentation of SARS-CoV-2 (COVID-19 in patients with congestive heart failure. A Retrospective study

Abstract

Background and Aims: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, has infected 86,468,659 people around the globe until 6/1/2021, with 1,869,808 mortalities. It is estimated that people with congestiveheart failure (CHF) are in a high risk category for mortality. Furthermore, persons with obesity who become ill and require intensive care present challenges in patient management as it is more difficult to intubate these persond, and this is especially true in Saudi Arabia and the region of Hail, where morbid obesity is at 33.6% of the population. Our aim is to establish an epidimiological link for our population between diabetes, obesity and percentage of intubated patients as we measured mortalities and readmissions in 30 days. Methods: A retrospective cohort study of 751 patients admitted as positive COVID 19 patients, from April 1, 2020 to July 31, 2020, covering a period of 4 months. We then categorised the patient in cohorts accordind to the existence of CHF or not, and categorised them according to their BMI index. We then correlated using statistical tool analysis - SPSS statistics tool - intubation, mortality,readmitance in 30 days in thes groups of patients Results: Around 12% of our cases were CHF. 16% of these cases intubated, instead of 5% of non CHF cases. Mortalities were higher in the CHF group as percentage ( 72% to 7%), and readmissions. Significant correlation between BMI and days of ICU stay in the CHF group Conclusions: There is significantly elevated morbidity and mortality at obese CHF cases with COVID 19